[1]
N. Gautam and A. Mishra, “Formulation and Characterization of Repaglinide Chitosan Nanoparticles for the Treatment of Diabetes Mellitus Type II”, Cur Res Pharm Sci, vol. 8, no. 4, pp. 270-277, Jan. 2019.